Michael J. Mitten
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 2%
- Multiple Myeloma Research and Treatments
Papers in
-
- Cancer therapeutics and mechanisms 5
- Cell death mechanisms and regulation 4
-
- Pneumonia and Respiratory Infections 5
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Co-authors
- Saul H. Rosenberg (8 shared papers)Steven W. Elmore (7 shared papers)Stephen W. Fesik (6 shared papers)Christin Tse (6 shared papers)Stephen K. Tahir (4 shared papers)Alexander R. Shoemaker (4 shared papers)Kennan C. Marsh (5 shared papers)Xiao Yu (4 shared papers)
- Journals
- Molecular Cancer Therapeutics (6 papers)Antimicrobial Agents and Chemotherapy (5 papers)Blood (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- United StatesUnited KingdomPortugal
In The Last Decade
Michael J. Mitten
27 papers receiving 2.9k citations
Michael J. Mitten's Hit Papers
Peers
Comparison fields: 5 of 95
- Genetics 331
- Hematology 348
- Oncology 774
- Molecular Biology 1.9k
- Microbiology 98
Countries citing papers authored by Michael J. Mitten
This map shows the geographic impact of Michael J. Mitten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Mitten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Mitten more than expected).
Fields of papers citing papers by Michael J. Mitten
This network shows the impact of papers produced by Michael J. Mitten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Mitten. The network helps show where Michael J. Mitten may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael J. Mitten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor Hit paper breakdown → | 2008 | 1589 |
| 2 | 2016 | 227 | |
| 3 | 2008 | 165 | |
| 4 | 2016 | 144 | |
| 5 | 2011 | 122 | |
| 6 | 2003 | 122 | |
| 7 | 2010 | 104 | |
| 8 | 2000 | 95 | |
| 9 | 2008 | 65 | |
| 10 | 2017 | 55 | |
| 11 | 2020 | 31 | |
| 12 | 2017 | 27 | |
| 13 | 2001 | 26 | |
| 14 | 1999 | 19 | |
| 15 | 2004 | 18 | |
| 16 | 1994 | 17 | |
| 17 | 1995 | 17 | |
| 18 | 1998 | 14 | |
| 19 | 2012 | 13 | |
| 20 | 2021 | 9 |
About Michael J. Mitten
Michael J. Mitten is a scholar working on Molecular Biology, Epidemiology, Oncology, Hematology and Infectious Diseases, having authored 27 papers that have together received 2.9k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (5 papers), Cancer therapeutics and mechanisms (5 papers), Cell death mechanisms and regulation (4 papers), Bacterial Infections and Vaccines (3 papers), Cancer-related Molecular Pathways (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Genetics (331 citations), Hematology (348 citations), Oncology (774 citations), Molecular Biology (1.9k citations) and Microbiology (98 citations). Michael J. Mitten has collaborated with scholars based in United States, United Kingdom and Portugal. Frequent co-authors include Saul H. Rosenberg, Steven W. Elmore, Stephen W. Fesik, Christin Tse, Stephen K. Tahir, Alexander R. Shoemaker, Kennan C. Marsh, Xiao Yu, Sha Jin and Jessica Adickes. Their work appears in journals such as Molecular Cancer Therapeutics, Antimicrobial Agents and Chemotherapy, Blood, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.